Gefitinib would not improve survival: Researchers closed a clinical trial comparing gefitinib (Iressa™) vs. a placebo for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes because review of data indicated that Gefitinib would not improve survival rates.

Human Trials Start in 30 Days: "Peregrine Pharmaceuticals Inc. said Monday that an animal version of its cancer treatment Tarvacin showed significant reduction in tumors in both lung and pancreatic cancers, and activity against prostate, fibrosarcoma and breast cancers."

Sunshine and Lung Cancer Surgery: "Lung Cancer Patients who had surgery in very sunny months and had a high intake of vitamin D were more than twice as likely to surpass the five-year survival mark as people who had winter surgeries and a low intake of vitamin D."

Software Solution to Help Pinpoint Lung Cancer in CT Scans iCAD(R), Inc. , announced that it has submitted an application with the FDA seeking clearance to market and sell its first product for use in the detection of lung cancer.

Peter Jennings, the 66 year old "World News Tonight" anchor for ABC, announced last week that he has lung cancer.

Frankly Speaking About Lung Cancer, A book Focusing on Small Cell Lung Cancer is now available for free. info@thewellnesscommunity.org

A 2005 Canadian Cancer Society Report shows that lung cancer remains the leading cause of cancer death for both men and women in Canada.

People who are at High Risk for lung Cancer, but are still asymptomatic, who are over 45 to 50 years of age and are current or former cigarette smokers, should enroll in clinical trials that offer screening for lung cancer.